Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» CAR-T
CAR-T
It’s official: Roche is a Car-T player
EP Vantage
Wed, 08/3/22 - 10:42 am
Roche
CAR-T
oncology
Poseida Therapeutics
Celyad gets the go-ahead to resume CAR-T trial for colorectal cancer as FDA lifts hold
Endpoints
Mon, 08/1/22 - 11:54 pm
Celyad
CAR-T
colorectal cancer
FDA
clinical trials
Bristol Myers CAR-T sales rise despite production problems
BioPharma Dive
Wed, 07/27/22 - 06:44 pm
Bristol Myers Squibb
cell therapy
earnings
CAR-T
J&J partner Legend Biotech looks to raise $250M amid Carvykti rollout, global expansion
Fierce Pharma
Wed, 07/27/22 - 10:28 am
JNJ
Legend Biotech
Carvykti
CAR-T
Legend scraps early-stage CAR-T for lymphoma 6 weeks after clinical hold lifted
Fierce Biotech
Fri, 07/8/22 - 10:32 am
Legend Biotech
CAR-T
cell therapy
clinical trials
lymphoma
LB1901
Amidst Legal Battle, BMS' CAR-T Therapy Scores Second FDA Approval
BioSpace
Mon, 06/27/22 - 06:32 pm
Bristol Myers Squibb
CAR-T
Breyanzi
liso-cel
FDA
large B-cell lymphoma
In first M&A strike, Paul Stoffels lays out 5-year plan to turn Galapagos around
Fierce Biotech
Thu, 06/23/22 - 10:54 am
Galapagos
Pharma CEOs
Paul Stoffels
M&A
CAR-T
AboundBio
CellPoint
Galapagos to enter cell therapy space with acquisition of CellPoint and AboundBio
Seeking Alpha
Tue, 06/21/22 - 11:50 pm
Galapagos
cell therapy
CellPoint
AboundBio
CAR-T
Bristol Myers Squibb takes its CAR-T patent case to US' top court in bid to revive $1.2B verdict against Gilead
Fierce Pharma
Thu, 06/16/22 - 10:48 pm
Bristol Myers Squibb
Gilead Sciences
patents
CAR-T
Juno Therapeutics
Taking Charge—biotechs already approaching Novartis to partner on 'game changing' CAR-T platform
Fierce Biotech
Tue, 06/14/22 - 11:18 am
Novartis
CAR-T
cell therapy
T-Charge
CRISPR Tx Drug Targeting CD70 Offers Early Hope for Difficult T Cell Lymphomas
BioSpace
Mon, 06/13/22 - 10:48 am
CRISPR Therapeutics
clinical trials
CTX130
CAR-T
solid tumors
T-cell lymphoma
The hangover: Caribou's allogeneic CAR-T hit by durability doubts as half of patients relapse
Fierce Biotech
Fri, 06/10/22 - 10:55 am
Caribou Biosciences
CRISPR
CAR-T
allogenic CAR-T
EHA
non-Hodgkin's lymphoma
Precision hails phase 1/2 data as proof it could deliver the first approved off-the-shelf CAR-T
Fierce Biotech
Wed, 06/8/22 - 11:00 pm
Precision Biosciences
CAR-T
gene therapy
gene editing
non-Hodgkin lymphoma
ASCO 2022 – Carvykti casts a long shadow
EP Vantage
Mon, 06/6/22 - 10:01 am
ASCO 2022
Carvykti
CAR-T
Arcellx
Gracell
Oricell
Multiple Myeloma
Novartis (NVS) Wins FDA Nod for Label Expansion of Kymriah
Yahoo/Zacks.com
Tue, 05/31/22 - 10:41 am
Novartis
FDA
Kymriah
CAR-T
relapsed or refractory follicular lymphoma
ASCO: J&J, Legend reveal more CAR-T data and a look at Carvykti for earlier myeloma in a difficult population
Fierce Pharma
Fri, 05/27/22 - 10:33 am
ASCO 2022
JNBJ
Legend Biotech
Carvykti
CAR-T
Multiple Myeloma
Inceptor Bio generates $37m in funding round as it advances CAR-T platform into the clinic
Biopharma Reporter
Wed, 05/25/22 - 10:13 am
Inceptor Bio
CAR-T
funding
cell therapy
cancer
CAR T without the toxicity: Kelonia gets $50M for a new take on cell therapy
MedCity News
Sun, 05/22/22 - 09:06 pm
Kelonia Therapeutics
CAR-T
cell therapy
funding
Inceptor Bio raises $37m from Series A to advance CAR-T lead program
Pharmaceutical Business Review
Fri, 05/20/22 - 10:32 am
Inceptor Bio
funding
CAR-T
Bayer pulls plug on $670M CAR-T cell therapy pact with Atara in wake of patient death
Fierce Biotech
Fri, 05/20/22 - 10:22 am
Bayer
Atara Biotherapeutics
patient death
CAR-T
clinical trials
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »